第25回日本内分泌学会北海道支部学術集会 JES WE Can 北海道支部賞 桑原 咲
{ 128件 }
第25回日本内分泌学会北海道支部学術集会 JES WE Can 北海道支部賞 桑原 咲
第25回日本内分泌学会北海道支部学術集会 若手優秀演題賞 住田 無限
日本糖尿病学会 第59回北海道地方会 若手奨励賞 最優秀賞 住田 無限
Rei Narimatsu, Ryuji Matsumoto, Haruka Miyata, Takahiro Osawa, Daisuke Abo, Kento Wakabayashi, Utano Tomaru, Hiraku Kameda, Izumi Fukuda, Takashige Abe Solitary fibrous tumor with Doege-Potter syndrome successfully treated with preoperative arterial embolization and complete excision; A case report IJU Case Reports, in press 英文・症例報告 IF 0.6
Oe Y, Nomoto H*, Cho KY, Omori T, Nakamura K, Takahashi A, Suzuki Y, Yoshikawa J, Kato-Sato A, Furukawa S, Nishio T, Kitakawa H, Miya A, Kameda H, Nakazawa D, Nakamura A, Sakai K, Atsumi T Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study Ther Adv Endocrinol Metab, in press 英文・原著 IF 4.6, 5Y-IF 4.8, Q1 journal
Takahisa Handa, Hiraku Kameda, Yuki Oe, Kiyoshi Sakai, Akinobu Nakamura, Tatsuya Atsumi "A Novel ARMC5 Germline Variant in Siblings with Primary Bilateral Macronodular Adrenal Hyperplasia and Colonic Adenomas" JCEM Case Reports, in press 英文・症例報告 IFなし
Shun Onodera, Masashi Miyamae, Issei Higuchi, Shunsuke Nashimoto, Akinobu Nakamura, Mitsuru Sugawara, Yoh Takekuma
The Effect of Sacubitril/Valsartan on Urinary C-Peptide Excretion and Endogenous Insulin Secretory Capacity in a Patient with Type 2 Diabetes: A Case Report J Pharm Health Care Sci, in press
Kei Yokozeki, Hiraku Kameda, Aika Miya, Shigeki Jin, Kotaro Matoba, Akinobu Nakamura, Tatsuya Atsumi
Blood steroid hormone profile and clinical outcomes following switching from metyrapone to osilodrostat in patients with Cushing disease
Endocr J, in press
IF=2.1
Saki Kuwabara, Hiraku Kameda, Kei Yokozeki, Aika Miya, Hiroshi Nomoto, Kyu Yong Cho, Akinobu Nakamura, Naohide Koyanagawa, Kohei Yamamoto, Jun Takeuchi, So Nagai, Arina Miyoshi, Norio Wada, Shinji Taneda, Yoshio Kurihara, Tatsuya Atsumi.
Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes. Endocr J, in press. IF 1.9
Yuki Oe、Takashi Omori、Eriko Aimono、Shin Furukawa、Hirohiko Kitakawa、Masatoshi Tateno、Kiyoshi Sakai、Kyu Yong Cho. Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide. Front. Endocrinol., 26 May 2025
Volume 16 - 2025 IF=3.9